El interés corto en Qualigen Therapeutics Inc (NASDAQ:QLGN) ha disminuido durante el último período de informe, aumentando en descenso desde 187.13K hasta 155.21K. Esto representa el 9.16% de las acciones disponibles públicamente de la empresa.
El interés en corto en Qualigen Therapeutics Corp (XNAS:QLGN) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 263.16K acciones negociadas por día, tomaría 1 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
QLGN | Qualigen Therapeutics, Inc. Co | 10/15/2025 | 10/24/2025 | 9.16% | 1,695,070 | 155,210 | 263,164 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 09/30/2025 | 10/09/2025 | 11.04% | 1,695,070 | 187,127 | 8,562,488 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 09/15/2025 | 09/24/2025 | 2.33% | 1,695,070 | 39,494 | 38,422 | 1.03 | |
QLGN | Qualigen Therapeutics, Inc. Co | 08/29/2025 | 09/10/2025 | 2.03% | 1,694,880 | 34,368 | 41,882 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 08/15/2025 | 08/26/2025 | 2.15% | 1,694,880 | 36,506 | 66,355 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 3.22% | 1,634,905 | 52,725 | 4,255,750 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 3.40% | 735,861 | 25,038 | 23,494 | 1.07 | |
QLGN | Qualigen Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 3.69% | 735,861 | 27,135 | 14,976 | 1.81 | |
QLGN | Qualigen Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 3.78% | 735,861 | 27,806 | 5,851 | 4.75 | |
QLGN | Qualigen Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 4.02% | 735,861 | 29,549 | 9,120 | 3.24 | |
QLGN | Qualigen Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 4.74% | 735,861 | 34,886 | 16,292 | 2.14 | |
QLGN | Qualigen Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 6.08% | 735,861 | 44,743 | 75,014 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 6.97% | 735,861 | 51,262 | 118,119 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 16.24% | 735,861 | 119,498 | 109,923 | 1.09 | |
QLGN | Qualigen Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 9.52% | 735,861 | 70,049 | 7,937 | 8.83 | |
QLGN | Qualigen Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 10.23% | 735,861 | 75,274 | 9,769 | 7.71 | |
QLGN | Qualigen Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 12.09% | 735,861 | 88,939 | 30,539 | 2.91 | |
QLGN | Qualigen Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 14.11% | 735,861 | 103,816 | 176,565 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 9.44% | 735,861 | 69,479 | 18,743 | 3.71 | |
QLGN | Qualigen Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 11.87% | 735,861 | 87,325 | 31,393 | 2.78 | |
QLGN | Qualigen Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 13.29% | 735,861 | 97,815 | 34,839 | 2.81 | |
QLGN | Qualigen Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 13.62% | 735,861 | 100,237 | 78,521 | 1.28 | |
QLGN | Qualigen Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 12.82% | 735,861 | 94,369 | 110,195 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | — | 736,430 | 779,440 | 13,667,463 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 0.41% | 26,993,539 | 110,185 | 126,358 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 0.40% | 26,993,539 | 108,951 | 172,036 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 1.02% | 26,993,539 | 275,585 | 457,351 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 2.27% | 26,993,539 | 613,357 | 277,412 | 2.21 | |
QLGN | Qualigen Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 2.11% | 11,356,383 | 239,613 | 1,317,068 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 36.67% | 11,356,383 | 4,164,577 | 70,159,594 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 5.96% | 9,587,452 | 571,453 | 7,449,176 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 1.53% | 6,280,924 | 96,269 | 431,959 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 1.27% | 6,280,924 | 79,797 | 184,459 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 1.25% | 6,280,924 | 78,457 | 110,803 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 0.69% | 6,280,924 | 43,090 | 40,852 | 1.05 | |
QLGN | Qualigen Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 0.79% | 6,280,924 | 49,405 | 77,398 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 1.27% | 6,280,924 | 79,932 | 89,756 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 0.23% | 5,151,161 | 11,630 | 66,199 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 0.20% | 5,151,161 | 10,363 | 77,042 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 02/15/2024 | 02/27/2024 | 0.55% | 5,151,161 | 28,539 | 58,246 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 0.57% | 5,151,161 | 29,357 | 23,313 | 1.26 | |
QLGN | Qualigen Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 0.67% | 5,151,161 | 34,389 | 57,230 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 0.41% | 5,151,161 | 20,973 | 41,721 | 1 | |
QLGN | Qualigen Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 0.61% | 5,151,161 | 31,198 | 19,964 | 1.56 | |
QLGN | Qualigen Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 0.66% | 5,151,161 | 33,901 | 11,276 | 3.01 | |
QLGN | Qualigen Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 0.78% | 5,151,161 | 40,282 | 16,441 | 2.45 | |
QLGN | Qualigen Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 0.80% | 5,022,566 | 40,027 | 20,902 | 1.91 |
En busca de los valores más cortos?